Glutathione's regulatory status depends on the form and how it is used. Some forms or uses are legal, while others are not approved by the U.S. FDA for human use and are not lawful to administer. The specific status of each use is described in the content below.
Status as of July 15, 2026
Glutathione reaches the consumer through several delivery forms that travel very different channels, and price and access track that split closely. Oral supplements sit at the cheap, ungated end, sold as dietary supplements without a prescription, while injectable and intravenous preparations are compounded and dispensed through clinics or telehealth at a much higher cost. Because insurers rarely cover wellness or cosmetic use, nearly all of this spending is out of pocket, and the figure that matters for most purchasers is the cumulative monthly or annual cost rather than the per-unit sticker.
Glutathione retails from roughly fifteen to sixty dollars a month for over-the-counter oral supplements up to one hundred fifty dollars or more per intravenous infusion session, and it is almost always paid out of pocket because insurers rarely cover wellness or cosmetic use.
Oral glutathione is the least expensive route by a wide margin, and formulation is the single biggest lever on the number. Plain capsules sit at the bottom while absorption-marketed liposomal liquids and sublingual lozenges cost meaningfully more. The honest comparison is price per gram of active glutathione, not price per bottle, since dose per serving varies as much as the shelf price does.
A thirty-day supply of oral glutathione typically runs fifteen to forty dollars for standard capsules and forty to seventy dollars for liposomal or sublingual formulations, and supplement pricing reflects brand positioning as much as ingredient cost, so a higher sticker does not reliably signal better bioavailability.
Injectable and intravenous glutathione carry sharply higher prices than oral products because a clinical service is bundled into every dose. Most of what the patient pays is not the compounded glutathione, which is comparatively cheap, but nurse or physician time, sterile supplies, and facility overhead. The delivery channel shifts the number substantially, from lower-cost telehealth vials up to concierge in-home infusion at the top.
A single intramuscular glutathione injection generally runs twenty-five to seventy-five dollars and a full intravenous infusion one hundred to two hundred fifty dollars, with most of that price representing clinical labor, sterile supplies, and facility overhead rather than the comparatively cheap compounded glutathione itself.
The largest single driver is delivery form, because an oral capsule, a liposomal liquid, a compounded vial, and an administered IV sit on entirely different cost structures even when the underlying molecule is identical. Layered on top are manufacturing standard and regulatory category, and a large, often invisible share of the retail number is brand positioning rather than raw ingredient cost.
Delivery form is the single largest driver of glutathione price variation, with manufacturing standard, regulatory category, and brand positioning layered on top, which is why two capsules carrying the same milligram dose can differ two- or threefold in retail price.
Availability splits cleanly along the line between supplement and medical product. Oral glutathione is effectively ubiquitous and reachable within minutes with no gatekeeper, while injectable and intravenous forms are compounded by specialty pharmacies and reach patients only through clinics, medical spas, and telehealth services. The widest availability carries the greatest hazard: gray-market and overseas online sellers ship injectable glutathione without prescription or verified sterility, and products from those channels carry documented risks of contamination, mislabeling, and unverified potency.
| Dimension | Oral supplements | Injectable and IV |
|---|---|---|
| Access point | Pharmacies, health-food stores, big-box, online | Compounding pharmacies via clinics, med-spas, telehealth |
| Gatekeeper | None; obtainable within minutes | Prescriber or clinical supervision required |
| Supply chain | Mass-manufactured retail stock | Compounded per prescription, not a branded drug |
Oral glutathione is sold without a gatekeeper through pharmacies, retailers, and online marketplaces, while injectable and intravenous forms reach patients only through compounding pharmacies dispensing on prescription via clinics, medical spas, and telehealth services.
The prescription question turns entirely on delivery route. Oral glutathione is regulated as a dietary supplement rather than a drug, so it sells over the counter as long as it makes no disease-treatment claim, with no prescriber or pharmacist between the consumer and the purchase. Injectable and intravenous forms occupy a different regulatory world, prepared by compounding pharmacies and dispensed only under a prescription because anything introduced past the digestive tract raises sterility, dosing, and adverse-reaction concerns the supplement framework does not address.
Oral glutathione is sold over the counter as a dietary supplement, while injectable and intravenous glutathione have no FDA-approved branded product and are dispensed only on a prescription or under direct clinical supervision as compounded preparations.
Delivery form sets both ends of the tradeoff at once, and the pattern is consistent: the harder a form is to obtain, the more it costs and the more absorption it promises. Access maps neatly onto a ladder that runs from wholly open retail for oral and topical products, to prescriber-gated but self-administered intramuscular vials, to fully clinic-dependent IV infusions.
| Form | Typical cost | Access level |
|---|---|---|
| Oral capsules | Tens of dollars a month | Open retail, no gatekeeper |
| Liposomal or sublingual | Higher than capsules, still OTC | Open retail |
| Topical creams and lotions | Modest, cosmetic-focused | Open retail |
| Intramuscular vial | Cheaper than IV | Prescriber-gated, self-administered |
| IV infusion | Highest per session | Clinic-dependent |
Across glutathione delivery forms, claimed bioavailability, price, and gatekeeping rise together, running from open-retail oral capsules at tens of dollars a month, through prescriber-gated intramuscular vials, to clinic-administered intravenous infusions at the highest per-session cost.
For the overwhelming majority of purchasers, glutathione is a fully out-of-pocket expense. Insurers decline it in the wellness, anti-aging, and cosmetic contexts where it is most often sought, treating those uses as elective and lacking the approved-indication evidence reimbursement requires, and supplements as a category are generally excluded outright. The practical consequence is that the sticker price is the real price, which pushes cost-conscious buyers toward the cheaper oral forms.
Glutathione is a fully out-of-pocket expense for the overwhelming majority of purchasers, because insurers treat wellness, anti-aging, and cosmetic use as elective and generally exclude dietary supplements from coverage.
Because any benefit from glutathione is pursued through sustained dosing rather than a one-time purchase, the honest cost figure is annual, and the two forms diverge dramatically over a year. Dosing frequency is the hinge, since a per-session or per-bottle price that looks reasonable in isolation compounds quickly once it repeats every week or month, which is why the per-unit number badly understates the cost of sustained results.
Because glutathione's claimed benefits depend on sustained dosing, the honest figure is annual, running roughly two hundred to seven hundred dollars a year for daily oral use versus two to five thousand dollars a year for a monthly clinical injection or infusion schedule.
Educational use only. This article describes what the published scientific and clinical literature reports about Glutathione. It is not medical advice, and it does not recommend, prescribe, or tell anyone to use anything described here. The regulatory status shown at the top of this page reflects what the record showed on the date given there and can change. mdpep.com does not sell any substance described here, does not endorse human use of it, and does not direct anyone to obtain it.
This is not guidance for your situation. Nothing here accounts for your medical history, your current medications, or anything else specific to you, and none of it should be used to make a decision about your own health.
Affiliate disclosure. Some links on this site are affiliate links, and mdpep.com may earn a commission when they are used. That never affects what is written here, it is not an endorsement of any vendor, and it is not a statement that anything described on this page is available to buy.
Every claim here ties to a named primary source and a date, written as plain documentation with nothing for sale. That is how MD PEP covers the whole peptide market.
